Page last updated: 2024-11-05

tranexamic acid and Drug-Induced Stevens Johnson Syndrome

tranexamic acid has been researched along with Drug-Induced Stevens Johnson Syndrome in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"To report a case of toxic epidermal necrolysis (TEN) induced by orally administered tranexamic acid in a patient with liver cirrhosis and acute rectal bleeding."3.79Tranexamic acid-induced toxic epidermal necrolysis. ( Aguado Gil, L; Idoate Gastearena, MA; Marques Martin, L; Pretel Irazabal, M, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Adams, L1
Creamer, D1
Pretel Irazabal, M1
Marques Martin, L1
Aguado Gil, L1
Idoate Gastearena, MA1

Other Studies

2 other studies available for tranexamic acid and Drug-Induced Stevens Johnson Syndrome

ArticleYear
Controlling oral hemorrhages in Steven-Johnson syndrome/toxic epidermal necrolysis.
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1

    Topics: Administration, Topical; Antifibrinolytic Agents; Hospitals, University; Humans; Mouth Mucosa; Oral

2020
Tranexamic acid-induced toxic epidermal necrolysis.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Stevens-J

2013